America First Legal (AFL) has released documents indicating that the U.S. Food and Drug Administration’s (FDA) Division of General Endocrinology recommended the approval of puberty blockers for children, despite being aware that these drugs increase the risk of depression and suicidality.
The documents were obtained through a lawsuit filed by AFL on February 28, 2023, against the FDA. The lawsuit alleged that the FDA had illegally concealed records related to the off-label use of puberty blockers and cross-sex hormones in children.
Ian Prior, Senior Advisor at America First Legal, stated: “It is shocking and unacceptable that the FDA would admit that puberty blockers cause suicidal ideation and depression, yet in the same breath recommend their approval for transgender ‘medical’ procedures for children. The advocates of these brutal practices on children claim that they are necessary to prevent suicide and depression, but in reality, the treatments themselves cause the very thing they claim they are trying to prevent. This barbarism has no place in a civilized society and it’s time for the federal government to follow the lead of Europe in banning these experiments on children.”